PRLD
Prelude Therapeutics Incorporated
$1.26
$0.00(0.00%)
51
Overall
60
Value
66
Tech
28
Quality
Market Cap
$81.50M
Volume
84.90K
52W Range
$0.61 - $2.01
Target Price
$3.50
EPS Estimates Overview
| Current Quarter | $-0.41 | Next Quarter | $-0.31 |
| Current Year | $-1.55 | Next Year | $-1.23 |
| QoQ Growth | +24.4% | YoY Growth | +20.6% |
| 3Y EPS CAGR | +11.6% | Target Price | $3.50 |
| Consensus | Buy | Upside | +177.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $1.26 | 0% | 84.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW